In vitro drug susceptibility pattern of Mycoplasma alligatoris isolated from symptomatic American alligators (Alligator mississippiensis)

Journal of Zoo and Wildlife Medicine

Volumn 33, Issue 2, 2002, Pages 108-111

  Helmick, Kelly E ^a,b   Brown, Daniel R ^a   Jacobson, Elliott R ^a   Brown, Mary B ^a  

^a University of Florida College of Veterinary Medicine   (United States)

^b El Paso Zoo   (United States)

Author keywords

Alligator mississippiensis; American alligator; Antibiotic; Minimum inhibitory concentration; Mycoplasma; Mycoplasma alligatoris

Indexed keywords

ALLIGATOR; ALLIGATOR MISSISSIPPIENSIS; ALLIGATORINAE; ANIMALIA; BACTERIA (MICROORGANISMS); MYCOPLASMA; MYCOPLASMA ALLIGATORIS;

EID: 0442264237     PISSN: 10427260     EISSN: None     Source Type: Journal    
DOI: 10.1638/1042-7260(2002)033[0108:IVDSPO]2.0.CO;2     Document Type: Article

References (20)

1. Brown, D. R., T. L. Clippinger, K. E. Helmick, I. M. Schumacher, R. A. Bennett, C. M. Johnson, K. A. Vliet, E. R. Jacobson, and M. B. Brown. 1996. Mycoplasma isolation during a fatal epizootic of captive alligators (Alligator mississippiensis) in Florida. Int. Org. Mycoplasmol. Lett. 4: 42-43.
2. Brown, D. R., J. M. Farley, L. A. Zacher, J. M. Carlton, T. L. Clippinger, and M. B. Tully. 2001. Mycoplasma alligatoris sp. nov. from American alligators. Int. J. Syst. Evol. Microbiol. 51: 419-424.
3. Brown, M. B., G. S. McLaughlin, P. A. Klein, B. C. Crenshaw, I. M. Schumacher, D. R. Brown, and E. R. Jacobson. 1999. Upper respiratory tract disease in the gopher tortoise is caused by Mycoplasma agassizii. J. Clin. Microbiol. 37: 2262-2269.
4. Brown, D. R., M. F. Nogueira, T. R. Schoeb, K. A. Vliet, R. A. Bennett, G. W. Pye, and E. R. Jacobson. 2001. Pathology of experimental mycoplasmosis in American alligators. J. Wildl. Dis. 37: 671-679.
5. Brown, M. B., I. M. Schumacher, P. A. Klein, K. Harris, T. Correll, and E. R. Jacobson. 1994. Mycoplasma agassizii causes upper respiratory tract disease in the desert tortoise. Infect. Immun. 62: 4580-4586.
6. Clippinger, T. L., R. A. Bennett, C. M. Johnson, K. A. Vliet, S. L. Deem, J. Oros, E. R. Jacobson, I. M. Schumacher, D. R. Brown, and M. D. Brown. 2000. Morbidity and mortality associated with a new mycoplasma species from captive American alligators (Alligator mississippiensis). J. Zoo Wildl. Med. 31: 303-314.
7. Hannan, P. C. 2000. Guidelines and recommendations for antimicrobial minimum inhibitory concentration (MIC) testing against veterinary mycoplasma species. International research program on comparative mycoplasmology. Vet. Res. 31: 373-395.
8. Hannan, P. C. T., P. J. O'Hanlon, and N. H. Rogers. 1989. In vitro evaluation of various quinolone antibacterial agents against veterinary mycoplasmas and porcine respiratory bacterial pathogens. Res. Vet. Sci. 46: 202-211.
9. Hawkins, E. C., D. M. Boothe, A. Guinn, D. P. Aucoin, and J. Ngyuen. 1998. Concentration of enrofloxacin and its active metabolite in alveolar macrophages and pulmonary epithelial fluid of dogs. J. Vet. Pharmacol. Ther. 21: 18-23.
10. Jordan, F. T. W., S. Gilbert, D. L. Knight, and C. A. Yavari. 1989. Effects of Baytril, tylosin, and tiamulin on avian mycoplasmas. Avian Pathol. 18: 659-673.
11. Jordan, F. T. W., and B. K. Horrocks. 1996. The minimum inhibitory concentration of tilmicosin and tylosin for Mycoplasma gallisepticum and Mycoplasma synoviae and a comparison of their efficacy in the control of Mycoplasma gallisepticum infection in broiler chicks. Avian Dis. 40: 326-334.
12. Kirchhoff, H., K. Mohan, R. Schmidt, M. Runge, D. R. Brown, M. B. Brown, C. M. Foggin, P. Muvavarirwa, H. Lehmann, and J. Flossdorf. 1997. Mycoplasma crocodyli sp. nov., a new species from crocodiles. Int. J. Syst. Bacteriol. 47: 742-746.
13. Kirst, H. A., and G. D. Sides. 1989. New direction for macrolide antibiotics: pharmacokinetics and clinical efficacy. Antimicrob. Agents Chemother. 33: 1419-1422.
14. Mohan, K., C. M. Foggin, P. Muvavarirwa, J. Honywill, and A. Pawandiwa. 1995. Mycoplasma-associated polyarthritis in farmed crocodiles (Crocodylus niloticus) in Zimbabwe. Onderstepoort J. Vet. Res. 62: 45-49.
15. Penner, J. D., E. R. Jacobson, D. R. Brown, H. P. Adams, and C. L. Besch-Williford. 1997. A novel Mycoplasma sp. associated with proliferative tracheitis and pneumonia in a Burmese python (Python molurus bivit-tatus). J. Comp. Pathol. 117: 283-288.
16. Senterfit, L. B., D. Taylor-Robinson, J. A. Robertson, C. Bebear, and G. Laber. 1986. Antibiotic sensitivity testing of mycoplasmas. International Organization for Mycoplasmology, Edmonton, Alberta, Canada.
17. ter Laak, E. A., J. H. Noordergraaf, and M. H. Verschure. 1993. Susceptibilities of Mycoplasma bovis, Mycoplasma dispar, and Ureaplasma diversum strains to antimicrobial agents in vitro. Antimicrob. Agents Chemother. 37: 317-321.
18. ter Laak, E. A., A. Pijpers, J. H. Noordergraaf, E. C. Schoevers, and J. H. M. Verheijden. 1991. Comparison of methods for in vitro testing of susceptibility of porcine Mycoplasma species to antimicrobial agents. Antimicrob. Agents Chemother. 35: 228-233.
19. Tully, J. G., R. F. Whitcomb, H. F. Clark, and D. L. Williamson. 1977. Pathogenic mycoplasmas. Cultivation and vertebrate pathogenicity of a new spiroplasma. Science 195: 892-894.
20. Williams, P. P. 1978. In vitro susceptibility of Mycoplasma hyopneumoniae and Mycoplasma hyorhinis to fifty-one antimicrobial agents. Antimicrob. Agents. Chemother. 14: 210-213.